Axial Therapeutics to Present at Upcoming Conferences
January 05, 2024 08:05 ET
|
Axial Therapeutics
WOBURN, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Axial Therapeutics, a clinical-stage biotechnology company dedicated to the development of gut-targeted, small molecule therapeutics for neurological...
Spero Therapeutics Provides Corporate Update and 2024 Outlook
January 05, 2024 08:05 ET
|
Spero Therapeutics, Inc.
In 2H 2024, expect to provide Phase 2a topline proof-of-concept data from our wholly-owned lead program SPR720 in NTM-PD patients Initiated dosing in PIVOT-PO Phase 3 trial for tebipenem HBr in cUTI...
Largest Ever Real-World Evidence Study of Ambulatory Cardiac Monitoring Demonstrates Clinical Superiority of iRhythm's Zio Long-Term Continuous Monitoring Service
January 05, 2024 08:05 ET
|
iRhythm
CAMELOT is the largest published real-world comparative effectiveness analysis of ambulatory cardiac monitoring.
Australia Enterprise ICT Market Analysis and Future Outlook to 2027 - CAGR of 13.5% Forecast During 2022-2027 to Reach $147 billion in 2027
January 05, 2024 08:03 ET
|
Research and Markets
Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The "Australia Enterprise ICT Market Analysis and Future Outlook by Segments (Hardware, Software and IT Services)" report has been added to ...
Catalyst Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
January 05, 2024 08:02 ET
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or the “Company”) (Nasdaq: CPRX) announced today the pricing of an underwritten public offering of...
Mersana Therapeutics Announces Business Updates, Expected 2024 Milestones and Upcoming Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
January 05, 2024 08:01 ET
|
Mersana Therapeutics, Inc.
Enrollment in dose escalation and backfill cohorts continuing in Phase 1 clinical trial of XMT-1660, Dolasynthen B7-H4 ADC; expect to initiate expansion in Q2 2024 and announce initial clinical data...
MAPS Welcomes New Investors, Name Change for MAPS Public Benefit Corporation
January 05, 2024 08:01 ET
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
MAPS shares ownership of Lykos with mission-aligned investors, will continue to advance psychedelic research, change drug policy, and shape culture
Pono Capital Three, Inc. Receives Shareholder Approval of the Business Combination with Horizon Aircraft
January 05, 2024 08:00 ET
|
Robinson Aircraft Ltd
HONOLULU and TORONTO, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Robinson Aircraft Ltd., doing business as Horizon Aircraft (“Horizon Aircraft” or the “Company”), a hybrid electric Vertical TakeOff and...
Allegro MicroSystems to Present at Needham’s 26th Annual Growth Conference on January 19
January 05, 2024 08:00 ET
|
Allegro MicroSystems, Inc.
MANCHESTER, N.H., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. (“Allegro”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy...
Compass Pathways and Greenbrook TMS enter into three-year research collaboration agreement
January 05, 2024 08:00 ET
|
Compass Pathways; Greenbrook TMS
LONDON, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental...